Boston Private Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Boston Private Financial Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BPFH

Boston Private Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Boston Private Financial Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BPFH

NEW YORK–(BUSINESS WIRE)–
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Boston Private Financial Holdings, Inc. (NASDAQ: BPFH) to SVB Financial Group is fair to Boston Private shareholders. Under the terms of the merger agreement, Boston Private shareholders will receive 0.0228 shares of SVB common stock and $2.10 of cash for each share of Boston Private they own.

Halper Sadeh encourages Boston Private shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

The investigation concerns whether Boston Private and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Boston Private shareholders; (2) determine whether SVB is underpaying for Boston Private; and (3) disclose all material information necessary for Boston Private shareholders to adequately assess and value the merger consideration. On behalf of Boston Private shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Boston Private shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

ThreeD Capital Acquires Securities of Electric Metals (USA) Ltd. through Two Private Placements and Sheldon Inwentash to become Chairman

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce two investments, for a total of $530,000 in Electric Metals (USA) Ltd. (“EML ”), a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.

In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.

In the second private placement, The Company has acquired 1,000,000 Subscription Receipts (the “Sub Receipts”) at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant. The Warrants will expire two (2) years from the date of issuance.

EML signed a definitive scheme implementation agreement, effective 31st December 2020, with NBS Capital Inc. (“NBS”) (TSXV: NBS.P), as announced yesterday by NBS. Pursuant to this Agreement, NBS will acquire all of the shares of EML via share exchange for an equivalent number of NBS shares, which will result in EML becoming a wholly owned subsidiary of NBS. NBS will change its name change to Nevada Silver Corporation on closing of the proposed transaction, reflecting the focus of EML on its principal Nevada silver asset.

Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.

Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated “ThreeD Capital prides itself on discovering great companies before they become known to the general investment community, and EML is no exception. With 100% ownership of a US-based primary silver-gold asset with existing resources and significant upside potential, I am confident EML will deliver exceptional value to IDK shareholders.”

Gary Lewis, Director and CEO of EML commented, “We are delighted to welcome ThreeD Capital onto the EML register and Mr. Sheldon Inwentash as our incoming Chairman at such a pivotal time in the company’s development. EML has built a strong asset base and technical capability which, when coupled with the reputation, rolodex and investment nous of Mr. Inwentash, will make for a very compelling combination.”

This Press Release is available on the ThreeD Capital verified forum on AGORACOM. The forum is live and can be found at https://agoracom.com/ir/threedcapital/forums/discussion

About Electric Metals (USA) Ltd.

EML is an unlisted public company incorporated under the laws of New South Wales, Australia. It is a U.S.-based resource company, with its material asset being the 100-per-cent-owned Corcoran Canyon silver project in Nevada. EML also holds a high-grade manganese project in Minnesota, United States.

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.

For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900 ext 106

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Forward-Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.



Broccolini Announces a Major Partnership for the Redevelopment of the Centre Kirkland

MONTREAL, Jan. 05, 2021 (GLOBE NEWSWIRE) — Broccolini Real Estate Group is announcing a major partnership with RioCan Real Estate Investment Trust for the redevelopment of the RioCan Centre Kirkland and the surrounding area, in light of the upcoming arrival of the REM in the West Island and of the future Kirkland REM station. This new project will consist of the complete revitalization of the site through the addition of new buildings that will make better use of the available space and propose a diversified offering of commercial, office and residential uses.

This represents a long-term commitment for Broccolini who will be responsible for the design and construction of the project and will then take over the management of the office spaces and handle the marketing of the residential component. Broccolini’s partner RioCan will be responsible for the property management of the retail/residential components. Once complete, the joint project between Broccolini and RioCan will include approximately 240,000 sq. ft. of office space and 135,000 sq. ft. of commercial space, to which will be added the residential component.

“This multi-phase project will be developed in close collaboration with the community and with the municipal authorities of the City of Kirkland,” says Roger Plamondon, President of the Broccolini Real Estate Group. “Our goal is to facilitate access to the REM by increasing the residential offering in this area, which will be adjacent to the new Kirkland station. The best way to achieve this is to design a project that meets the needs of the community, both in terms of density and mix of uses,” explains Plamondon. According to the current projections, the Kirkland REM station is slated to be operational by 2023-2024.

About Broccolini
Broccolini is a leading single-source provider of construction, development and real-estate services in Canada. The company caters to the industrial, commercial, institutional, and residential markets and provides a wide range of services, acting variously as a general contractor, construction manager, project manager, property manager and developer. Broccolini’s Real Estate Management subsidiary currently owns and manages a portfolio of more than 40 properties, representing a total of over 11 million square feet of assets.

AVAILABILITY FOR INTERVIEWS
President of the Broccolini Real Estate Group, Roger Plamondon, is available for interviews this Monday, January 4th.

SOURCE: Broccolini

For more information:
Jean Langlois, Director, Communications and Marketing
514 737-0076
[email protected]



Sun Life cautions investors regarding Obatan LLC bid for shares

PR Newswire

TORONTO, Jan. 5, 2021 /PRNewswire/ – Sun Life Financial Inc. (the “Company” or “Sun Life”) (TSX: SLF) (NYSE: SLF) has been notified that Obatan LLC (“Obatan”) has made an unsolicited “mini-tender offer” to purchase up to 50,000 common shares of Sun Life or approximately 0.0085% of the common shares outstanding at a price of US$35 per share.

Sun Life is not associated with Obatan and does not recommend or endorse acceptance of this unsolicited offer.

Sun Life cautions that Obatan’s offer has been made at a price that is significantly lower than recent market prices for Sun Life shares on Canadian and U.S. stock exchanges. This offer represents a discount of 19.90% and 19.84% respectively below the closing price of Sun Life’s common shares on the TSX and NYSE on December 18, 2020, the last trading day before the mini-tender offer was commenced and a discount of 20.94% and 20.80% respectively  below the closing prices on the TSX and NYSE on January 4, 2021.

Securities administrators in Canada and the United States recommend that investors exercise caution with “mini-tender offers”.   Mini-tender offers are designed to avoid disclosure and procedural requirements applicable to most bids under Canadian and U.S. securities regulations. Canadian Securities Administrators and the U.S. Securities and Exchange Commission (SEC) have expressed serious concerns about mini-tender offers, including the possibility that investors might tender to such offers without understanding the offer price relative to the actual market price of their securities.

The SEC has indicated that “bidders make mini-tender offers at below-market prices, hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price.”

According to Obatan’s offer documents, Sun Life shareholders who have already tendered their shares can withdraw their shares at any time before 8:00 P.M. New York City Time on February 2, 2021 by following the procedures described in the offer documents. Shareholders are cautioned that the terms of the Obatan offer may be varied, and the cash consideration offered may be decreased. In such a case, shareholders who have already tendered to the offer may have limited notice of such change and limited time to withdraw their shares from the offer.  There are also no assurances that Obatan will buy the shares delivered under the offer.

Shareholders and policyholders should carefully review the Obatan offer documents, consult with their Sun Life advisor or investment advisor to discuss any offer they may receive and review all options they have for their investment in Sun Life shares. If you are in Canada and do not have a Sun Life advisor and are interested in finding one, please visit https://www.sunlife.ca/en/find-an-advisor/.

Sun Life has stock transfer agents providing shareholder services in Canada, the United States, the United Kingdom, Hong Kong and the Philippines. These local agents provide services directly to our registered shareholders and can provide information on share account management, direct deposit of dividends, dividend reinvestment and share purchase plans. Please email [email protected] for more information.

Sun Life requests that a copy of this news release be included in any distribution of materials relating to Obatan’s mini-tender offer for Sun Life common shares.

About Sun Life

Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of September 30, 2020, Sun Life had total assets under management of $1,186 billion. For more information please visit www.sunlife.com.

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.

Note to editors: All figures in Canadian dollars

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/sun-life-cautions-investors-regarding-obatan-llc-bid-for-shares-301201074.html

SOURCE Sun Life Financial Inc.

Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration Statement

No Offer of New Securities; Registration Statement Permits Resale of Common Stock from Warrant Financing Exercises

DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (Nasdaq: MBII) (MBI),  a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Form S-3 resale registration statement relating to the potential resale of shares of common stock, including common stock issuable upon the exercise of warrants held by certain shareholders per the Company’s previously announced warrant transaction, has been declared effective by the U.S. Securities and Exchange Commission (“SEC”) on January 5, 2021.

“This registration statement was filed to comply with the terms of our warrant restructuring transactions that we previously announced in April of 2020, and to facilitate the cash exercise of the warrants to finance our operations,” said Jim Boyd, Chief Financial Officer of Marrone Bio Innovations. “We are not offering any new securities, and we will not receive any proceeds from the resale of stock under this Form S-3. However, while the registration statement remains effective, we will continue to receive proceeds from the cash exercise of the April 2020 warrants.”

Securities registered pursuant to the registration statement are not required to be sold, and the registration of the securities does not necessarily indicate that any stockholder intends to sell its securities. The registration statement, while effective, permits resale of the securities already issued or issuable from warrants and covered by the registration statement, subject to the satisfaction by the seller of the securities with the prospectus delivery requirements of the Securities Act of 1933.

The offering of the securities covered by the registration statement may only be made by means of a prospectus. The registration statement and prospectus may be accessed through the SEC’s website at www.sec.gov. A copy of the prospectus related to the offering may be obtained from Marrone Bio Innovations, Inc., 1540 Drew Avenue, Davis, California 95618, Attention: Investor Relations, or by calling (530) 750-2800.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state or jurisdiction in which the offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Marrone Bio Innovations


Marrone Bio Innovations Inc.
 (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company’s product pipeline. MBI’s Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.

Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: TwitterLinkedIn and Instagram.

Marrone Bio Innovations Forward Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties.  All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date.  Examples of such statements include statements regarding the potential cash exercise of warrants and potential resales of common stock under the prospectus. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, any difficulty in marketing MBI’s products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, and adverse decisions by regulatory agencies and other relevant third parties.  Additional information that could lead to material changes in MBI’s performance is contained in its filings with the Securities and Exchange Commission.  MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Marrone Bio Innovations Contacts:

Kevin Helash, CEO
Jim Boyd, President and CFO
Telephone: +1 (530) 750-2800
Email: [email protected]

Investor Relations Contact:

Lucas A. Zimmerman
Senior Vice President
MZ Group – MZ North America
Main: 949-259-4987
[email protected]
www.mzgroup.us



ALERT: Halper Sadeh LLP Investigates HMSY, RLH, MTSC, CATM; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:


HMS Holdings Corp. (NASDAQ: HMSY)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Gainwell Technologies for $37.00 in cash per share. If you are an HMS shareholder, click here to learn more about your rights and options.


Red Lion Hotels Corporation (NYSE: RLH)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sonesta International Hotels Corporation for $3.50 per share in cash. If you are a Red Lion shareholder, click here to learn more about your rights and options.


MTS Systems Corporation (NASDAQ: MTSC)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Amphenol Corporation for $58.50 per share in cash. If you are an MTS shareholder, click here to learn more about your rights and options.


Cardtronics plc (NASDAQ: CATM)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds managed by affiliates of Apollo Global Management, Inc. and Hudson Executive Capital LP for $35.00 per share in cash. If you are a Cardtronics shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  



Maine Launches e-Filing in Select Courts With Tyler Technologies’ eFileMaine Solution

Maine Launches e-Filing in Select Courts With Tyler Technologies’ eFileMaine Solution

Statewide business and consumer court and Bangor-area courts offer e-filing and access to electronic court records

PLANO, Texas–(BUSINESS WIRE)–Tyler Technologies, Inc. (NYSE: TYL) announced today that the Maine Judicial Branch (MJB) has successfully gone live with Tyler’s Odyssey File & Serve™ solution, eFileMaine™. The solution allows the MJB to electronically review and accept court case filings from litigants.

The MJB, a unified state court system, selected Tyler’s Odyssey File & Serve solution after an extensive RFP process. Odyssey File & Serve is a primary component of the state’s new e-filing court case management system (eFCMS). Another component is a public web portal that enables the public, attorneys, and other stakeholders to have self-service access using a computer and web-browsing technology.

A key component of the eFCMS initiative is electronic filing. Tyler’s solution enables e-filing for all litigants to support the MJB’s mission: to administer justice by providing a safe, accessible, efficient and impartial system of dispute resolution that serves the public interest, protects individual rights, and instills respect for the law. eFiling is now available for litigants in the Penobscot County Superior Court, Bangor District Court, and the statewide business and consumer court, and will eventually be available in all Maine courts across the state for all case types.

“As a long-term technology partner to the Maine Judicial Branch, we’re proud to announce the successful go-live of electronic filing in Maine,” said Rusty Smith, president of Tyler’s Courts & Justice Division. “Maine has been able to optimize its court filings and document management with the help of Tyler’s solutions, bringing benefits such as decreased file processing time, a reduction in physical storage, and a decrease in cost-per-transaction with automated document processing.”

With the successful implementation of eFileMaine, the MJB is empowering its litigants to file court documents electronically. In addition, the MJB can access filed case documents via one centralized location, easily track electronic service history and status for users, and view a master list of all parties that receive electronic filing service on a particular case.

Maine is the 16th state client to deploy Odyssey File & Serve, joining states such as Illinois, Indiana, Minnesota, Oregon, and Texas.

More than 2 million registered users submit electronic filings through Tyler’s Odyssey File & Serve solution annually. The solution processes more than 45 million e-filings and 215 million pages every year.

About Tyler Technologies, Inc.

Tyler Technologies (NYSE: TYL) provides integrated software and technology services to the public sector. Tyler’s end-to-end solutions empower local, state, and federal government entities to operate more efficiently and connect more transparently with their constituents and with each other. By connecting data and processes across disparate systems, Tyler’s solutions are transforming how clients gain actionable insights that solve problems in their communities. Tyler has more than 26,000 successful installations across more than 10,000 sites, with clients in all 50 states, Canada, the Caribbean, Australia, and other international locations. Tyler was named to Forbes’ “Best Midsize Employers” list in 2019 and has been recognized three times on Forbes’ “Most Innovative Growth Companies” list. More information about Tyler Technologies, an S&P 500 company headquartered in Plano, Texas, can be found at tylertech.com.

Jennifer Kepler

Tyler Technologies

972.713.3770

[email protected]

KEYWORDS: United States North America Maine Texas

INDUSTRY KEYWORDS: Courts Data Management Technology Public Policy/Government Software

MEDIA:

Logo
Logo

Airgain® to Present at the 23rd Annual Needham Growth Conference on January 13, 2021

Airgain® to Present at the 23rd Annual Needham Growth Conference on January 13, 2021

SAN DIEGO–(BUSINESS WIRE)–Airgain, Inc. (NASDAQ: AIRG), a leading provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including consumer, enterprise, and automotive, has been invited to present at the 23rd Annual Needham Growth Conference, which is being held virtually on January 11-15, 2021.

Airgain management is scheduled to present on Wednesday, January 13, 2021 at 12:30 p.m. Eastern time, with one-on-one meetings to be held the same day. The company’s presentation will be webcast live and available for replay here.

For additional information or to schedule a one-on-one meeting with Airgain management, please contact your Needham representative or Gateway Investor Relations at (949) 574-3860 or [email protected].

About Airgain, Inc.

Airgain is a leading provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including consumer, enterprise, and automotive. Combining design-led thinking with testing and development, Airgain works in partnership with the entire ecosystem, including carriers, chipset suppliers, OEMs, and ODMs. Airgain’s antennas are deployed in carrier, fleet, enterprise, residential, private, government, and public safety wireless networks and systems, including set-top boxes, access points, routers, modems, gateways, media adapters, portables, digital televisions, sensors, fleet, and asset tracking devices. Airgain is headquartered in San Diego, California, and maintains design and test centers in the U.S., U.K., and China. For more information, visit airgain.com, or follow us on LinkedIn and Twitter.

Airgain and the Airgain logo are registered trademarks of Airgain, Inc.

Airgain Company Contact

Jules Cassano

Director of Marketing

Airgain, Inc.

[email protected]

Airgain Investor Contact

Matt Glover

Gateway Group, Inc.

+1 949 574 3860

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Networks Internet Mobile/Wireless Technology Telecommunications

MEDIA:

Logo
Logo

Study of patients undergoing abdominal aortic aneurysm repair suggests screening guidelines may be inadequate

Study published in Journal of Vascular Surgery

Rosemont, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) — A retrospective study analyzing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current AAA screening guidelines may be inadequate in detecting a significant number of new cases. Additionally, expanding screening for certain population segments may be warranted. The study patients were enrolled in the Vascular Quality Initiative between years 2003 and 2019.

The study was spearheaded by Jeffrey E. Indes, MD, vascular surgeon at Montefiore Einstein Center for Heart and Vascular Care, and results were published in the December 2020 edition of the Journal of Vascular Surgery.

Few diagnoses are as devastating as a ruptured AAA. Ruptured AAAs were responsible for close to 10,000 deaths in 2017 and represent the 15th leading cause of death in the United States.

“Screening can lead to elective AAA repair, which has a far lower mortality than ruptured AAA,” said first author Matthew L. Carnevale, MD, of the Montefiore Health System and Albert Einstein College of Medicine. “The mortality rate for a patient with a ruptured AAA who never makes it to a hospital is exceedingly high. For those who do make it to a hospital, the 30-day mortality rates vary between 20 and 50%.”

Screening guidelines derived from the 2005 U.S. Preventive Services Task Force (USPTF) recommendations involve a one-time abdominal ultrasound examination only for men aged 65-75 with a history of smoking. An update published in December 2019 added selective screening only for men aged 65-75 without a history of smoking.

In 2018, the Society for Vascular Surgery (SVS) suggested including women aged 65-75 with a history of smoking. Additionally, the SVS expanded its criteria to include: first-degree relatives of those with an AAA, and anyone older than 75 with a history of smoking and who is fit for repair.

Amongst those cases, the percentage of patients that would have been captured via screening depended on the guidelines used:

  • USPTF                             32% Endovascular Aneurysm Repair (EVAR)           33% open
  • SVS                                 38% Endovascular Aneurysm Repair EVAR              45% open
  • Expanded SVS                 72% Endovascular Aneurysm Repair (EVAR)            66% open

Thus, even when using the most liberal guidelines, 27% of EVAR and 33% of open cases would not have met any screening criteria.

Of all those who did not meet screening criteria, ruptured AAA was twice as prevalent as those who did meet the criteria (9% vs 4%, P<.0001).

“These findings suggest an investigation into expanding the scope of current screening protocols is warranted,” said Carnevale. “With adequate screening protocols, we are able to identify disease at an early stage, thereby monitoring the progression and potentially improving the outcome for more patients with AAA,” said Carnevale.

“Our study additionally describes the clinical characteristics and outcomes in patients undergoing EVAR and open surgery who did not meet the currently accepted screening guidelines. The two distinct populations identified include those under the age of 65 (mainly 40-59) with a significant smoking history and those over 65 (mainly over 75) with no smoking history; these two groups may warrant future investigation,” he said.

Typically treated by a vascular surgeon, to keep AAA symptoms from worsening, patients may be advised to avoid tobacco products, follow a healthy diet, keep blood pressure and cholesterol levels under control and exercise regularly.

To download the full journal article, visit http://vsweb.org/JVS-AAAscreeningStudy.

About the Society for Vascular Surgery

The Society for Vascular Surgery is the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease. SVS seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness and is composed of specialty-trained vascular surgeons who are dedicated to providing comprehensive care for vascular disease. For more information visit www.vascular.org. Follow the SVS on Facebook @VascularHealth, Twitter @VascularSVS and Instagram @societyforvascularsurgery.

###



Beth Richman
Society for Vascular Surgery
312-806-8999
[email protected]

MTBC Predicts Increased Consolidation and Technology Adoption in 2021, Alongside Other Healthcare Trends

SOMERSET, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) —

MTBC, Inc.
 (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services predicts six key healthcare trends for 2021 including an increase in vendor consolidation, technology adoption, patient consumerism, and a renewed synergy between providers and experienced business partners.

“During 2020, we all relied on front-line healthcare provider heroes who, in turn, embraced new healthcare delivery strategies to succeed,” said Stephen Snyder, CEO, MTBC. “As we consider 2021, our team makes six key predictions about our industry in the year ahead, which have been inspired by internal data, industry trends, our intuitions, and MTBC’s client survey involving physicians, administrators, and practice leaders, across more than 30 specialties.”

Healthcare vendor consolidation will continue to accelerate.

2020 saw high levels of investment and M&A activity in the healthcare space, including a record number of special purpose acquisition companies (SPACs) and digital health acquisitions. In fact, while MTBC has been acquiring companies for 15 years, it closed its two largest acquisitions during 2020.

“We believe that the same drivers that accelerated healthcare M&A activity and investment during 2020 will continue through 2021 and beyond,” said Snyder. “Increased consolidation will continue to enable healthcare vendors to obtain the scale, technology, expertise, and efficient operating models needed to succeed in the emerging healthcare paradigm.”

Providers will adopt modern, cloud-based solutions and services.

COVID-19 has accelerated the digital transformation of healthcare, and technology will continue to be top-of-mind for both providers and patients. Practices will prioritize data-driven, cloud-based solutions, software and services that support their financial, clinical, and administrative workflows and aid in business continuity.

“We predict that practices will continue to focus on innovation in order to achieve optimal performance and provide unmatched patient care,” said Hadi Chaudry, President, MTBC. “Practices have relied on innovative technology, automation, and strategic alliances to get through the pandemic, and we believe that this trend will continue to accelerate. More specifically, expect to see practices embracing technologies such as robotic process automation (RPA) in 2021 as they strive to optimize workflows.”

In a survey conducted by MTBC in which practices were asked about their technology use in 2020, nearly half said they had embraced new solutions due to the outbreak and would continue to do so in 2021.

Healthcare providers will demand experienced partners who support business continuity.

As the complexity of the healthcare market continues to evolve, growing reimbursement challenges, increased competition and rising operating costs will push providers to seek experienced, proven vendors whose technology-enabled solutions and deep operational strength free up limited practice resources, allowing them to focus on improving care delivery and outcomes.

“Providers will put a higher value on third-party relationships in order to leverage operational scale while improving both the top and bottom lines,” said Al Nardi, Senior Vice President of Strategy, MTBC. “We expect more providers to rely on the expertise of third-party vendors who bring measurable results, strategic insights and a partnership-centric approach to their practices as the market continues to stabilize.”

Practices large and small will continue to gravitate towards vendors who offer a broader suite of software-enabled solutions – which allow practices to quickly scale and expand as they navigate both challenges and opportunities in the coming year.

More providers will embrace automation and analytics.

“The pandemic has permanently shifted the healthcare landscape, causing providers to re-evaluate their business strategies,” said Norman Roth, Controller, MTBC. “In 2021, practices will further focus on automation and analytical software to optimize key operational functions, increase efficiency, and optimize workflows. There will be an ongoing drive to turn fixed costs into variable costs, using business support services and innovative solutions to achieve operational excellence.”

“Expect practices to place high value on practice resiliency,” said Bill Korn, CFO, MTBC. “They will hone in on revitalizing revenue cycle management, saving money, and optimizing front and back-end operations. They will demand cloud-based electronic health records and practice management so they have full access to systems wherever employees decide to work, and will prioritize business intelligence to allow them to manage during periods of uncertainty. They will prize working with third-parties who have resources and track record to prove they can be counted upon.”

Patient consumerism will drive practice modernization.

With patients becoming responsible for even more of their care costs, coupled with a growing desire for a more modern practice experience, consumerism will continue to play a significant role in the patient/physician relationship in 2021.

“The involved patient is much more likely to view operational and communication standards more heavily when choosing a provider than they did in years prior,” said Wes Stolp, Executive Vice President of Sales, MTBC. “Patients will continue to view innovative platforms as operational must-haves.”

As a result of pandemic challenges, practices will continue to experience a swing in patient preferences, including a stronger desire for contactless functionalities such as intake, payment and communication.

Telehealth services will continue to grow.

Telehealth usage exploded in early 2020 as COVID-19 began to spread across the U.S. Expect telehealth to continue to gain traction in the ‘new normal’ of 2021.

“Since January of 2020, we’ve seen the percentage of telehealth encounters increased exponentially, and when we asked our clients whether or not they expected telehealth utilization would persist post-pandemic, more than half said yes,” said Adeel Sarwar, Chief Technology Officer, MTBC. “Now that our clients have integrated telehealth technology into their practices, patients have come to expect telehealth as a standard care option. Practices will continue to provide virtual care services even after the pandemic is over.”

Since practices will continue to rely on telehealth in 2021 and beyond, it is vital that reimbursement rates continue to adapt. While providers anticipate telehealth to continue as a standard care option, it’s important to keep in mind that virtual care availability will greatly depend on telehealth reimbursement codes and whether or not they revert to pre-COVID levels. This is why MTBC is advocating on behalf of physicians regarding the future of CMS telehealth guidelines and reimbursement.

MTBC management will discuss these key trends for the 2021 healthcare industry at the H.C. Wainwright BIOCONNECT virtual event, January 11 – 14, 2021. Investors can listen to a webcast of the fireside chat with Kevin Dede, Managing Director of Equity Research at H.C. Wainwright at ir.mtbc.com/events starting at 8 am EST on January 11.

For more insight into how practices view the future of healthcare after this historical year, view the survey results from MTBC’s 2021 Healthcare Provider Outlook.

About MTBC

MTBC is a healthcare information technology company that provides a full suite of proprietary cloud-based solutions, together with related business services, to healthcare providers and hospitals throughout the United States. Our Software-as-a-Service (or SaaS) platform includes revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth and patient experience management (PXM) solutions for high-performance medical groups. MTBC helps clients increase financial and operational performance, streamline clinical workflows and make better business and clinical decisions, allowing them to improve patient care while reducing administrative burdens and operating costs. MTBC’s common stock trades on the Nasdaq Global Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the Nasdaq Global Market under the ticker symbol “MTBCP.”

For additional information, please visit our website at www.mtbc.com. To view MTBC’s latest investor presentation, read press releases, and listen to interviews with management, please visit ir.mtbc.com.

Follow MTBC on LinkedInTwitter and Facebook.

Forward Looking Statement

This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of the COVID-19 pandemic on our financial performance and business activities, and the expected results from the integration of our acquisitions.

These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. In addition, there is uncertainty about the spread of the COVID-19 virus and the impact it may have on the Company’s operations, the demand for the Company’s services, and economic activity in general.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE MTBC

Company Contact:

Bill Korn
Chief Financial Officer
MTBC, Inc.
[email protected]

Investor Contact:

Matt Kreps
Managing Director
Darrow Associates Investor Relations
[email protected]
(214) 597-8200

Media Inquiries:

Mike Cuesta
Chief Marketing Officer
MTBC, Inc.
[email protected]